“I think 2026 is the year of fundamental, agentic transformation of the workflow.” Abridge co-founder and CTO Zack Lipton joins Bloomberg Intelligence analyst Jonathan Palmer to share how the company grew from a research-heavy idea into one of health care’s breakout AI leaders. Lipton breaks down the limits of point solutions, the complexity of evaluating generative AI in medicine, and why he sees the future not as a better digital scribe alone, but as a unified platform that can guide documentation, billing and care decisions in real time.

7Wire's Jaffee on the Hard Truths Behind Health-Tech Investing
42:12

Xaira’s War on Trial-and-Error Drug Development
52:46

AVS’ Toland on Next Lithotripsy Launch
40:01